268
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Fixed-dose combination therapy of candesartan cilexetil and amlodipine besilate for the treatment of hypertension in Japan

, , , &
Pages 577-583 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jung-Ryul Kim, Seokuee Kim, Wooseong Huh & Jae-Wook Ko. (2018) No pharmacokinetic interactions between candesartan and amlodipine following multiple oral administrations in healthy subjects. Drug Design, Development and Therapy 12, pages 2475-2483.
Read now
Niki Katsiki, Vasilios G. Athyros & Asterios Karagiannis. (2013) Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?. Journal of Drug Assessment 2:1, pages 67-71.
Read now

Articles from other publishers (5)

Balasubramaniyan Vairappan, Gavin Wright, Sundhar M & T.S. Ravikumar. (2023) Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF. European Journal of Pharmacology 958, pages 176010.
Crossref
Yan-Qiong Cheng, Bing-Yi Tan, Xu-Hong Yu, Wen-Zhe Dong, Ding-Feng Su, De-Qiu Zhu & Ai-Jun Liu. (2018) Synergism of amlodipine and candesartan on blood pressure reduction and organ protection in hypertensive rats. Clinical and Experimental Pharmacology and Physiology 45:6, pages 514-524.
Crossref
Xudong Zhao & Xietong Wang. (2018) Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway. Molecular Medicine Reports.
Crossref
Balasubramaniyan Vairappan. (2015) Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress. World Journal of Hepatology 7:3, pages 443.
Crossref
Pitchai Balakumar & Gowraganahalli Jagadeesh. 2015. Pathophysiology and Pharmacotherapy of Cardiovascular Disease. Pathophysiology and Pharmacotherapy of Cardiovascular Disease 751 806 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.